ArticleHealth science reports2025
Demographics, Trends, and Cardiovascular Mortality in Kaposi Sarcoma Patients in the United States: An Analysis of Surveillance, Epidemiology, and End Results Database.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kaposi sarcoma (KS) is a vascular neoplasm caused by human herpesvirus-8. There is a paucity of data on the cause of death in patients with KS, especially the proportion of cardiovascular mortality. This study aimed to provide annual trends, demographic analysis, and cause of death analysis of KS in the United States. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was used to collect data from 2000 to 2020 from 17 registries. Results: We identified 8247 patients with KS, with majority males (90.6%) and in the 40-59 age range (38.5%). More than half of the patients were single (53.8%). Hispanic patients constituted 23.9% of the population, while 23.1% were non-Hispanic Black patients. Overall, the incident burden of KS decreased, but there was no significant change in the incident burden of KS among females. Furthermore, no significant change in incident burden was observed among the Hispanic and Black populations. Similarly, annual incident burden among single and never-married individuals has been decreasing since 2014. Patients with KS and primarily cutaneous features (skin KS) have a favorable survival rate compared to those with visceral KS ( Conclusions: Our study provides significant insights into cardiovascular mortality among patients with KS and highlights annual trends, demographic distribution, and mortality rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.